Tuesday, November 17, 2026

EPS Holdings and Logos Science Form Capital Alliance! Jointly promoting the provision of solutions in the area of mental health

EPS Holdings and Logos Science have formed a capital alliance as strategic partners with the aim of jointly promoting the provision of solution services in the area of mental health!

Purpose of Capital Alliance

EPSHD has developed its outsourcing business in pharmaceutical and medical device development with CRO1, SMO2, and CSO*3 at its core.
We are conducting a management buyout (MBO) in 2021 and expanding our activities into new areas with the aim of becoming a solution company for the entire healthcare industry that transcends conventional boundaries.

Logos Science was founded in 2022 by Ig nobel laureate Hideki Tanemura with the aim of providing new solution services in the field of mental health. Based on joint research with the Institute for Applied Brain Science, Waseda University Integrated Research Organization, Logos Science is currently engaged in the development of a mental health self-care application "Dr. AppliⓇ" *4 that helps solve problems and troubles associated with stress-related disorders. The company is involved in the development of a mental health self-care application, "Dr. AppliⓇ" *4, based on joint research with the Institute for Applied Brain Science, Waseda University.

In a clinical study (feasibility study) to verify the feasibility of practical application, "Dr.appliⓇ" was evaluated for its usability and safety, and achieved favorable results, including significant improvements in outcome measures.

EPSHD and Logos Science will not only form a capital alliance, but will also work as strategic partners to solve social issues by combining EPSHD's knowledge in the healthcare field cultivated through its pharmaceutical and medical device development business with the psychotherapy program based on Logos Science's "Dr. AppsⓇ ". AppⓇ , and by combining EPSHD's knowledge in the healthcare field gained through its pharmaceutical and medical device development business with the psychotherapy program based on Logos Science's Dr. AppⓇ , EPSHD will develop self-care applications in the mental health field, build evidence for these applications, and promote marketing activities to solve social issues.

Details

In recent years, the number of patients with mental disorders has been on the rise, reaching approximately 4.2 million according to a patient survey conducted by the Ministry of Health, Labor and Welfare in 2017. Of these, depression, a stress-related disorder, accounts for the largest number at 1.27 million. In particular, suicides among young people, declining labor productivity due to presenteeism in companies, and the prevalence of vague anxiety in the recent Corona disaster have become social problems.

Early detection and prevention of stress-related illnesses has been emphasized by the Ministry of Health, Labor and Welfare (MHLW) through stress checks and other mental health and overwork measures in the workplace, but awareness of specific preventive measures and self-care methods is not widespread.

The "Dr. AppliⓇ" is currently being developed by Logos Science in collaboration with the Institute for Applied Brain Science, Waseda University, and is an application program that replicates cognitive behavioral therapy and other psychotherapies, including acceptance and commitment therapy (ACT), which are conducted by professionals in clinical psychology settings. The feasibility of its practical application was confirmed in a clinical feasibility study.

Related Press Releases
Developed and completed a clinical study (feasibility study) of "Dr. AppliⓇ ," an application that supports the resolution of problems and distress associated with stress-related illnesses
https://prtimes.jp/main/html/rd/p/000000001.000105323.html

By developing a mental health self-care application that combines such a psychotherapy program based on Logos Science's "Dr. AppⓇ " with EPSHD's knowledge in the healthcare domain cultivated through its pharmaceutical and medical device development business, early detection of mental health problems and high quality self-care methods will be provided to companies and individuals. By providing companies and individuals with a high quality self-care method, it is expected to lead to the prevention of mental health problems.

EPSHD and Logos Science will work together to bring a mental health self-care application especially for companies and workers to practical use in 2023.

The EPS Group, which is taking off to a new stage as a solution provider 30 years after its establishment, and Logos Science, which is taking on the challenge of research and development to provide new solution services in the mental health field, will synergize their efforts to create value that leads to social innovation. We aim to create value that leads to social innovation.

Details of Capital Alliance

EPSHD will acquire [90,000] shares of common stock issued by Logos Science for the purpose of promoting joint business in the area of mental health.

Date of investment contract

Date of investment agreement March 3, 2023

About EPS Holdings

Since its establishment in 1991 as a pioneer CRO, we have been a healthcare solutions provider offering new value to pharmaceutical and medical device companies, hospitals/clinics, and academia through our solutions in development, drug development, marketing, sales, consultation, etc., as well as our initiatives in Big Data & AI, regenerative medicine, etc. In 2021, we launched our drug discovery business and began providing clinical development support for seeds from academia and domestic and international bio-ventures, as well as marketing support services in Japan and overseas.

About Logos Science

Founded in 2022, we are engaged in the app/system development business for stress-related diseases and mental health care. We aim to realize wellbeing through the science of language, and contribute to the realization of a society without suffering by helping to solve social issues through our app/system development business for stress-related diseases and mental health care.

*1: CRO (Contract Research Organization)
*2: Site Management Organization (SMO)
*3: CSO (Contract Sales Organization)
*4: "Dr. AppliⓇ" is a registered trademark of Logos Science Inc.

name of companyLogos Science Corporation
EstablishmentFeb. 2022
LocationShin Toranomon Jitsugyo Kaikan 5F, 1-1-21 Toranomon, Minato-ku, Tokyo
representativeHideki Tanemura
uniform resouce locatorhttps://logossjp.com/
PORT Editorial Officehttps://port.creww.me/
PORT by Creww is an open innovation media for startups, entrepreneurs, entrepreneurs in recovery, and companies seeking to create new businesses on the theme of social issues, operated by Creww Co.
- Advertisment -
- Advertisment -

Featured

東芝のオープンイノベーション、協業検討に進む2社が決定 ダイナミックマッププラットフォームとArithmerを選定

ReGACY Innovation Group株式会社(東京都千代田区)は、企画・運営パートナーとして支援する株式会社東芝の「Toshiba OPEN INNOVATION PROGRAM 2026」で、協業検討に進む参加企業2社が決定したと発表した。7月に募集した共創プランの中から、ダイナミックマッププラットフォーム株式会社とArithmer株式会社を選定。両社は東芝グループの「Hybrid-3D LiDAR」と「気象データサービス」を活用し、物流・インフラ分野などでの新たなソリューション共創を目指す。12月中旬の成果発表会に向け、実証と事業性検証を進める。 本プログラムでは、2026年7月6日から7月26日まで参加企業を募集しており、応募のあった共創プランの中から、ダイナミックマッププラットフォーム株式会社、Arithmer株式会社の2社が選定されました。 両社は、東芝グループが保有する「Hybrid-3D LiDAR」および「気象データサービス」の技術・データを用いて、物流・インフラ分野やデータ活用領域における新たなビジネスソリューションの共創を目指します。 今後は、12月中旬に予定されている成果発表会に向けて実証や事業性検証を進めるとともに、事業化を見据えた協業の検討を加速していきます。

新潟日報社、オープンイノベーションプログラム2026ピッチ審査会で「三ツ目」「想ひ人」2社を選定

新潟日報社は8月4日、「新潟日報社 オープンイノベーションプログラム2026 ピッチ審査会」を開催した。Creww株式会社が提供する「Creww Growth」を活用し、5月15日から6月15日にかけて新潟県や社会が抱える課題解決に向けた協業アイデアを募集。応募61件の中から書類審査を通過した8社がピッチに参加し、審査の結果「三ツ目」(新潟県三条市)と「想ひ人」(東京都)の2社を選定した。今後は実証事業等を通じて事業化を進める予定。

【ヤマサキ × BeeInventor】高温下での過酷な作業環境から、データは命を守れるか——創業151年の工業炉建設会社とスマートヘルメット新興企業が挑む「熱中症ゼロ」の現場

明治8年創業の株式会社ヤマサキは、建設業界向けアクセラレータープログラム「ヤマサキ×オープンイノベーションプログラム2024」を通じて、スマートヘルメットを手がけるビーインベンターとのPoCを実施した。内部温度800度を超える製鉄炉の傍らで働く現場作業員の熱中症リスクをAIで早期検知するという挑戦は、今まさに第2フェーズへと移行しようとしている。プロジェクトリーダーの向井裕一氏と、BeeInventor(ビーインベンター)のNao SeoChon氏に話を伺った。

【ヤマサキ × CHAOSRU】「誰も知らない技術」を、誰もが体験できる価値へ——創業151年の工業炉建設会社とVRスタートアップが挑む、採用×認知の壁の壊し方

明治8年創業の株式会社ヤマサキは、製鉄に欠かせない築炉の技術を持ちながら、業界・企業の認知度の壁が採用の課題となっていた。この課題の突破口を探るべく参加したのが、『ヤマサキ×オープンイノベーションプログラム2024』だ。プログラムを通じて、VR・XR技術を核とする株式会社CHAOSRUとの協業をスタート。2025年7月から始まったPoC(実証実験)では、高校生向け採用説明会へのVR体験の導入により、ブース来訪者数に明らかな変化が生まれている。アクセラレータープログラムを通じたスタートアップとの協業で何が動き、何が見えてきたのか。株式会社ヤマサキのプロジェクトリーダー 田中敏彦氏と、CHAOSRU代表取締役の内藤薫氏に話を伺った。